Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells

Neuroscience Letters

Volumn 351, Issue 2, 2003, Pages 83-86

  Wang, Qian ^a   Li, Hong ^a   Wang, Xiao Wei ^a   Wu, Da Chang ^a   Chen, Xiao Yan ^a   Liu, Jia ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 3; Differentiation; Fas; FasL; Medulloblastoma; Resveratrol

Indexed keywords

CASPASE 3; FAS ANTIBODY; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; RESVERATROL;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TUMOR CELL LINE; UPREGULATION;

EID: 0142165219     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.07.002     Document Type: Article

References (20)

1. Bernhard D., Tinhofer I., Tonko M., Hubl H., Ausserlechner M.J., Greil R., Kofler R., Csordas A. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ. 7:2000;834-842.
2. Bhat K.P., Lantvit G. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 61:2001;7456-7463.
3. Boughton B. Childhood cancer treatment causes complications later in life. Lancet Oncol. 3:2002;390.
4. Clement M.V., Hirpara J.L., Chawdhury S.H., Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 92:1998;996-1002.
5. Dorrie J., Gerauer H., Wachter Y., Zunino S.J. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 61:2001;4731-4739.
6. Ehrlich P.F., Lamkin T. Unusual delayed complication of central venous access. J. Pediatr. Hematol. Oncol. 23:2003;472-473.
7. Harada K., Toyooka S., Maitra A., Maruyama R., Toyooka K.O., Timmons C.F., Tomlinson G.E., Mastrangelo D., Hay R.J., Minna J.D., Gazdar A.F. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene. 21:2002;4345-4349.
8. Jaboin J., Wild J., Hamidi H., Khanna C., Kim C.J., Robey R., Bates S.E., Thiele C.J. MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. Cancer Res. 62:2002;6108-6115.
9. Juan M.E., Vinardell M.P., Planas J.M. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr. 132:2002;257-260.
10. Keles G.E., Berger M.S., Srinivasan J., Kolstoe D.D., Bobola M.S., Silber J.R. Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol. Res. 7:1995;493-503.
11. Liu J., Li H., de Tribolet N., Jaufeerally R., Hamou M.F., Van Meir E.G. IL-6 stimulates growth and inhibits constitutive, protein synthesis-independent apoptosis of murine B-cell hybridoma 7TD1. Cell. Immunol. 155:1994;428-435.
12. Liu J., Guo L., Li J.W., Liu N., Li H. All-trans retinoic acid modulates fas expression and enhances chemosensitivity of human medulloblastoma cells. Int. J. Mol. Med. 5:2000;145-149.
13. Liu J., Guo L., Luo Y., Li J.W., Li H. All trans-retinoic acid suppresses in vitro growth and down-regulates LIF gene expression as well as telomerase activity of human medulloblastoma cells. Anticancer Res. 20:2000;2659-2664.
14. Louis D.N., Pomeroy S.L., Cairncross J.G. Focus on central nervous system neoplasia. Cancer Cell. 1:2002;125-128.
15. McNeil D.E., Cote T.R., Clegg L., Rorke L.B. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results. Med. Pediatr. Oncol. 39:2002;190-194.
16. Packer R.J., Cogen P., Vezina G., Rorke L.B. Medulloblastoma: clinical and biologic aspects. Neuro-oncology. 1:1999;232-250.
17. Rubin J.B., Rowitch D.H. Medulloblastoma: a problem of developmental biology. Cancer Cell. 2:2002;7-8.
18. Tsan M.F., White J.E., Maheshwari J.G., Bremner T.A., Sacco J. Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. Br. J. Haematol. 109:2000;405-412.
19. Wieder T., Prokop A., Bagci B., Essmann F., Be.rnicke D., Schulze-Osthoff K., Dorken B., Schmalz H.G., Daniel P.T., Henze G. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia. 15:2001;1735-1742.
20. Wu J.M., Wang Z., Hsieh T., Bruder J.L., Zou J.G., Huang Y.Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int. J. Mol. Med. 8:2001;3-17.